Related Experiment Video
Updated: Jun 22, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Obesity and metabolic disease
Richelle J Koopman1, Sarah J Swofford, Mark N Beard
1Curtis W. and Ann H. Long Department of Family and Community Medicine, University of Missouri, Columbia, MO 65212, USA. koopmanr@health.missouri.edu
Obesity significantly elevates diabetes risk. Overweight individuals with prediabetes should aim for 5-10% weight loss and 150 minutes of weekly physical activity to prevent diabetes progression.
Area of Science:
- Endocrinology
- Metabolic Health
- Preventive Medicine
Background:
- Obesity is a major risk factor for type 2 diabetes, increasing risk 10-fold.
- Overweight and obesity are associated with impaired glucose regulation.
Purpose of the Study:
- To outline recommendations for preventing diabetes progression in overweight and obese individuals.
- To provide guidance on screening for diabetes in at-risk populations.
Main Methods:
- Review of current guidelines and evidence regarding weight management and physical activity for diabetes prevention.
- Analysis of American Diabetes Association (ADA) screening recommendations for diabetes.
Main Results:
- Weight loss of 5%-10% and increased physical activity (≥150 min/wk) are recommended for overweight individuals with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG).
- ADA recommends diabetes screening (fasting glucose every 3 years) for individuals >45 years with BMI ≥25.
- Earlier or more frequent screening is advised for overweight individuals with additional diabetes risk factors.
Conclusions:
- Lifestyle interventions, including weight loss and physical activity, are crucial for preventing diabetes in at-risk individuals.
- Adherence to ADA screening guidelines is essential for early detection and management of diabetes.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Related Concept Videos
Obesity
Type II Diabetes I: Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Type II Diabetes II: Pathophysiology